Table 3 Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, non-Hispanic whites (95% CI in parentheses): Cancer sites with weaker evidence of an inverse association with UV-B exposure (see notes for Table 2).
From: Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002
Incidence | Mortality | |||
|---|---|---|---|---|
Cancer site | Males | Females | Males | Females |
Esophagus (females) | 1.08 (0.99–1.19) | 1.21 (1.14–1.28) | ||
Small intestine | 1.15 (1.03–1.28) | 1.20 (1.07–1.35) | 1.07 (0.93–1.22) | 1.24 (1.08–1.42) |
Gallbladder (males) | 1.13 (0.94–1.35) | 1.58 (1.38–1.82) | ||
Pancreas | 1.09 (1.05–1.14) | 1.17 (1.13–1.22) | 1.06 (1.03–1.09) | 1.11 (1.08–1.14) |
Breast | 1.06 (1.05–1.07) | 1.15 (1.13–1.17) | ||
Kidney | 1.09 (1.05–1.13) | 1.17 (1.11–1.22) | 1.12 (1.08–1.17) | 1.20 (1.14–1.25) |
Thyroid (females) | 1.10 (1.05–1.16) | 1.30 (1.16–1.47) | ||
Non-Hodgkin lymphoma | 1.08 (1.05–1.12) | 1.09 (1.05–1.12) | 1.12 (1.08–1.15) | 1.15 (1.12–1.18) |
Leukemia | 1.09 (1.04–1.13) | 1.15 (1.10–1.20) | 1.07 (1.03–1.10) | 1.09 (1.06–1.13) |